Opioid induced hypersensitivity: possible to avoid by different withdrawal regimens?

Phase 1

Active, not recruiting

• Conditions: Opioid Induced Hyperalgesia; MedDRA version: 14.0Level: LLTClassification code 10033376Term: Pain aggravatedSystem Organ Class: 10018065 - General disorders and administration site conditions; Therapeutic area: Body processes [G] - Chemical Phenomena [G02]

• Registration Number: EUCTR2011-002734-39-NO
• Lead Sponsor: Oslo University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-10-31
• Study Completion: 2012-12-31
• Last Update Posted: 8 October 2021

Recruitment & Eligibility

• Status: Not Recruiting
• Sex: Male
• Target Recruitment: 0

Inclusion Criteria

Healthy men, volunteers, age 18-60.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 16
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Drug abuse; permanent users of opioids/NSAID/steroids or other types of analgetics; chronic diseases; allergy to opioids.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified